Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

61.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.3K
RNA Splicing01:32

RNA Splicing

20.0K
20.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

26.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
26.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.5K
5.5K
Pre-mRNA Processing: RNA Splicing01:32

Pre-mRNA Processing: RNA Splicing

7.3K
7.3K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein.

Nature biotechnology·2026
Same author

Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding.

Nature·2026
Same author

Selective Elimination of TP53 Mutant Cells by Transcript-Activated Chromatin Shredding.

bioRxiv : the preprint server for biology·2026
Same author

A Noncontiguous Code for RNA-Guided DNA Recognition Preceded CRISPR.

bioRxiv : the preprint server for biology·2026
Same author

Programmable kinetic barcoding for multiplexed RNA detection with Cas13a.

Nature biomedical engineering·2026
Same author

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

medRxiv : the preprint server for health sciences·2026
Same journal

Complex Indel Detection: A Simulation-Based Framework and Parsing with FreeBayes.

bioRxiv : the preprint server for biology·2026
Same journal

Emulating the gingival-tooth interface during bacterial, fungal, and viral infection in a microphysiological model of the human oral cavity.

bioRxiv : the preprint server for biology·2026
Same journal

Local SNP-explained methylation variation reveals genetically anchored and exposure-associated methylation architecture in the human brain.

bioRxiv : the preprint server for biology·2026
Same journal

Perinatal Semaglutide Treatment Improves Maternal Health and Mitigates Offspring Metabolic Dysfunction in a Mouse Model of Maternal Obesity.

bioRxiv : the preprint server for biology·2026
Same journal

Pervasive cryptic selection in the human noncoding genome.

bioRxiv : the preprint server for biology·2026
Same journal

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K

Spligation enables programmable chimeric RNA generation in living cells.

David A Colognori1,2,3, Kevin M Wasko1,2, Marena I Trinidad1,4

  • 1Innovative Genomics Institute, University of California, Berkeley, CA, USA.

Biorxiv : the Preprint Server for Biology
|March 23, 2026
PubMed
Summary
This summary is machine-generated.

New CRISPR-Csm technology precisely deletes RNA sequences within transcripts, enabling novel RNA manipulation and therapeutic applications for human diseases.

More Related Videos

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.3K
Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.3K
Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.6K

Area of Science:

  • Molecular Biology
  • Genetic Engineering

Background:

  • Precise RNA modification is crucial for controlling genetic information flow, influencing transcript stability, localization, and translation.
  • Current RNA-targeting technologies like CRISPR-Csm, RNA knockdown, base editing, and trans-splicing have limitations for extensive transcript alterations.
  • Genome editing or endogenous splicing machinery are typically required for more significant transcript modifications.

Purpose of the Study:

  • To investigate the potential of type III-A CRISPR-Csm complexes for site-specific RNA deletions in human cells.
  • To explore the generation of chimeric transcripts through RNA ligation following CRISPR-Csm-mediated cleavage.
  • To demonstrate the application of this novel RNA manipulation technique in endogenous transcripts for therapeutic purposes.

Main Methods:

  • Utilized type III-A CRISPR-Csm complexes for programmable RNA cleavage and excision in human cells.
  • Fused CRISPR-Csm complexes with the RNA ligase RtcB to enhance deletion efficiency.
  • Developed and applied a "spligation" process combining CRISPR-Csm cleavage and trans-ligation to create chimeric transcripts.

Main Results:

  • CRISPR-Csm complexes successfully generated both short and long RNA excisions within target transcripts.
  • Fusion of Csm with RtcB significantly enhanced the efficiency of RNA deletion.
  • The spligation process was demonstrated to create chimeric transcripts from cleaved products of different RNA molecules.
  • Applied spligation to endogenous transcripts, generating recombinant mRNA independent of canonical splice sites.

Conclusions:

  • CRISPR-Csm complexes offer a powerful tool for precise, site-specific RNA deletions, expanding RNA manipulation capabilities.
  • The enhanced CRISPR-Csm-RtcB system and spligation technique enable novel RNA engineering strategies.
  • This approach holds significant potential for developing new therapeutic strategies for human diseases by precisely altering RNA molecules.